GlaxoSmithKline Co., Ltd.
グラクソスミスクライン株式会社
Ticker
—
Listed market
—
Country
Employees (non-consolidated)
—
Related companies
1
§01
Basic information
- Head office
- Chief executive
- Capital
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- End date
§02
Websites
§03
Business
PharmaceuticalsDrug DevelopmentDrug SalesVaccine ProductionMedical Information ProvisionDrug Research and DevelopmentDrug SalesMedical Information ServiceWebinars and Online LecturesVideo LibraryDrug Research, Development, Manufacturing, and SalesProvision of Medical Information ServicesProvision of Education and Training ServicesDistribution of Video Content
§04
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
| GlaxoSmithKline (Ireland) Limited |
Names without a link are companies not yet registered in OpenBizGraph
§05
Network
Drag to move · click to open
§06
History
In March 2009, in accordance with the Ministry of Health, Labour and Welfare's Director-General of Pharmaceutical Safety Notification (No. 935, dated September 19, 2000) titled "Handling of Pharmaceutical Display Items and Sale Names to Prevent Medical Accidents", the sale names were changed to "Botox 50 Units for Injection" and "Botox 100 Units for Injection".![]()
§07
News
There is no news.
§09
Sources & updates
DOMAINOwn domain:Yes
UPDATED2026-09-26 03:29 · Model: ggml-org/gpt-oss-20b